Literature DB >> 23797246

Neurodegenerative disease: 'fifty shades of grey' in the Huntington disease gene.

Ferdinando Squitieri.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23797246     DOI： 10.1038/nrneurol.2013.128

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN： 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  10 in total

1.  DNA stability and schizophrenia in twins.

Authors:  Giang H Nguyen; Joseph Bouchard; Monica G Boselli; Linda G Tolstoi; Louis Keith; Clinton Baldwin; Nam C Nguyen; Mark Schultz; Victoria L M Herrera; Cassandra L Smith
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2003-07-01       Impact factor: 3.568

2.  HD CAG repeat implicates a dominant property of huntingtin in mitochondrial energy metabolism.

Authors:  Ihn Sik Seong; Elena Ivanova; Jong-Min Lee; Yeun Su Choo; Elisa Fossale; MaryAnne Anderson; James F Gusella; Jason M Laramie; Richard H Myers; Mathieu Lesort; Marcy E MacDonald
Journal:  Hum Mol Genet       Date:  2005-08-22       Impact factor: 6.150

3.  Substance abuse may be a risk factor for earlier onset of Huntington disease.

Authors:  Joanne A Byars; Leigh J Beglinger; David J Moser; Pedro Gonzalez-Alegre; Peg Nopoulos
Journal:  J Neurol       Date:  2012-01-25       Impact factor: 4.849

4.  RORalpha-mediated Purkinje cell development determines disease severity in adult SCA1 mice.

Authors:  Heliane G Serra; Lisa Duvick; Tao Zu; Kerri Carlson; Sam Stevens; Nathan Jorgensen; Alana Lysholm; Eric Burright; Huda Y Zoghbi; H Brent Clark; J Michael Andresen; Harry T Orr
Journal:  Cell       Date:  2006-11-17       Impact factor: 41.582

5.  Microsatellite instability generates diversity in brain and sociobehavioral traits.

Authors:  Elizabeth A D Hammock; Larry J Young
Journal:  Science       Date:  2005-06-10       Impact factor: 47.728

6.  Characterization of the Huntington intermediate CAG repeat expansion phenotype in PHAROS.

Authors:  Annie Killoran; Kevin M Biglan; Joseph Jankovic; Shirley Eberly; Elise Kayson; David Oakes; Anne B Young; Ira Shoulson
Journal:  Neurology       Date:  2013-04-26       Impact factor: 9.910

7.  Measures of growth in children at risk for Huntington disease.

Authors:  Jessica K Lee; Kathy Mathews; Bradley Schlaggar; Joel Perlmutter; Jane S Paulsen; Eric Epping; Leon Burmeister; Peg Nopoulos
Journal:  Neurology       Date:  2012-07-18       Impact factor: 9.910

8.  DNA instability in postmitotic neurons.

Authors:  Roman Gonitel; Hilary Moffitt; Kirupa Sathasivam; Ben Woodman; Peter J Detloff; Richard L M Faull; Gillian P Bates
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-25       Impact factor: 11.205

9.  Psychiatric symptoms in Huntington's disease before diagnosis: the predict-HD study.

Authors:  Kevin Duff; Jane S Paulsen; Leigh J Beglinger; Douglas R Langbehn; Julie C Stout
Journal:  Biol Psychiatry       Date:  2007-05-03       Impact factor: 13.382

10.  Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington's disease age of onset.

Authors:  Nancy S Wexler; Judith Lorimer; Julie Porter; Fidela Gomez; Carol Moskowitz; Edith Shackell; Karen Marder; Graciela Penchaszadeh; Simone A Roberts; Javier Gayán; Denise Brocklebank; Stacey S Cherny; Lon R Cardon; Jacqueline Gray; Stephen R Dlouhy; Sandra Wiktorski; Marion E Hodes; P Michael Conneally; Jack B Penney; James Gusella; Jang-Ho Cha; Michael Irizarry; Diana Rosas; Steven Hersch; Zane Hollingsworth; Marcy MacDonald; Anne B Young; J Michael Andresen; David E Housman; Margot Mieja De Young; Ernesto Bonilla; Theresa Stillings; Americo Negrette; S Robert Snodgrass; Maria Dolores Martinez-Jaurrieta; Maria A Ramos-Arroyo; Jacqueline Bickham; Juan Sanchez Ramos; Frederick Marshall; Ira Shoulson; Gustavo J Rey; Andrew Feigin; Norman Arnheim; Amarilis Acevedo-Cruz; Leticia Acosta; Jose Alvir; Kenneth Fischbeck; Leslie M Thompson; Angela Young; Leon Dure; Christopher J O'Brien; Jane Paulsen; Adam Brickman; Denise Krch; Shelley Peery; Penelope Hogarth; Donald S Higgins; Bernhard Landwehrmeyer
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-01       Impact factor: 11.205
  10 in total
  5 in total

Review 1.  The Efficacy and Safety of Pridopidine on Treatment of Patients with Huntington's Disease: A Systematic Review and Meta-Analysis.

Authors:  Moamen Mostafa Asla; Asmaa Ahmed Nawar; Alaa Abdelsalam; Esraa Elsayed; Marwa Abdelazim Rizk; Mohamed Alaa Hussein; Walaa A Kamel
Journal:  Mov Disord Clin Pract       Date:  2021-10-29

2.  Terapeutic Potential of Microencapsulated Sertoli Cells in Huntington Disease.

Authors:  Giovanni Luca; Ilaria Bellezza; Iva Arato; Alba Di Pardo; Francesca Mancuso; Mario Calvitti; Giulia Falabella; Sara Bartoli; Vittorio Maglione; Enrico Amico; Mariagrazia Favellato; Giuseppe Basta; Maria Bodo; Alba Minelli; Riccardo Calafiore; Luigi Frati; Ferdinando Squitieri
Journal:  CNS Neurosci Ther       Date:  2016-05-26       Impact factor: 5.243

3.  Profile of pridopidine and its potential in the treatment of Huntington disease: the evidence to date.

Authors:  Ferdinando Squitieri; Justo Garcia de Yebenes
Journal:  Drug Des Devel Ther       Date:  2015-10-28       Impact factor: 4.162

4.  A Novel Triplet-Primed PCR Assay to Detect the Full Range of Trinucleotide CAG Repeats in the Huntingtin Gene (HTT).

Authors:  Alessandro De Luca; Annunziata Morella; Federica Consoli; Sergio Fanelli; Julie R Thibert; Sarah Statt; Gary J Latham; Ferdinando Squitieri
Journal:  Int J Mol Sci       Date:  2021-02-08       Impact factor: 5.923

5.  "Spazio Huntington": Tracing the Early Motor, Cognitive and Behavioral Profiles of Kids with Proven Pediatric Huntington Disease and Expanded Mutations > 80 CAG Repeats.

Authors:  Federica Graziola; Sabrina Maffi; Melissa Grasso; Giacomo Garone; Simone Migliore; Eugenia Scaricamazza; Consuelo Ceccarelli; Melissa Casella; Ludovica Busi; Barbara D'Alessio; Alessandro De Luca; Giovanna Stefania Colafati; Umberto Sabatini; Alessandro Capuano; Ferdinando Squitieri
Journal:  J Pers Med       Date:  2022-01-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.